Travere Therapeutics, Inc.

The current price of TVTX is 5.47 USD — it has increased by 3.90% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Travere Therapeutics, Inc. stocks are traded under the ticker TVTX.

Travere Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

TVTX stock is 6.30% volatile and has beta coefficient of 2.49. Check out the list of the most volatile stocks — is Travere Therapeutics, Inc. there?

TVTX earnings for the last quarter are 1.97 USD per share, whereas the estimation was −1.06 USD resulting in a 285.07% surprise. The estimated earnings for the next quarter are −1.16 USD per share. See more details about Travere Therapeutics, Inc. earnings.

Travere Therapeutics, Inc. revenue for the last quarter amounts to ‪33.93 M‬ USD despite the estimated figure of ‪57.33 M‬ USD. In the next quarter revenue is expected to reach ‪41.69 M‬ USD.

Yes, you can track Travere Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

TVTX stock has fallen by 5.29% compared to the previous week, the month change is a 29.39% fall, over the last year Travere Therapeutics, Inc. has showed a 73.00% decrease.

Today Travere Therapeutics, Inc. has the market capitalization of ‪400.28 M‬, it has decreased by 4.88% over the last week.

No, TVTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, TVTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Travere Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

TVTX reached its all-time high on Aug 15, 2003 with the price of 765.00 USD, and its all-time low was 0.18 USD and was reached on Jul 25, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 29, 2024, the company has 380.00 employees. See our rating of the largest employees — is Travere Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Travere Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Travere Therapeutics, Inc. stock shows the sell signal. See more of Travere Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Travere Therapeutics, Inc. future price: according to them, TVTX price has a max estimate of 21.00 USD and a min estimate of 9.00 USD. Read a more detailed Travere Therapeutics, Inc. forecast: see what analysts think of Travere Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Travere Therapeutics, Inc. EBITDA is ‪−294.68 M‬ USD, and current EBITDA margin is −232.87%. See more stats in Travere Therapeutics, Inc. financial statements.